UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 227

Sortiert nach

Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical hematopoietic stem cell transplantation: a single-center experience

Annals of hematology, 2020-06, Vol.99 (6), p.1389-1400

2020

Volltextzugriff (PDF)

Incidence, risk factors, and clinical outcomes associated with Epstein‐Barr virus‐DNAemia and Epstein‐Barr virus‐associated disease in patients after haploidentical allogeneic stem cell transplantation: A single‐center study

Clinical transplantation, 2020-06, Vol.34 (6), p.e13856-n/a

2020

Volltextzugriff (PDF)

Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia

Frontiers in immunology, 2021-05, Vol.12, p.605766-605766

2021

Volltextzugriff (PDF)

Immune reconstitution of HLA-A0201/BMLF1- and HLA-A1101/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell transplantation

Virology journal, 2019-02, Vol.16 (1), p.19-19, Article 19

2019

Volltextzugriff (PDF)

Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo

Leukemia research, 2010-05, Vol.34 (5), p.658-665

2010

Volltextzugriff (PDF)

Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study

Annals of hematology, 2021-06, Vol.100 (6), p.1579-1591

2021

Volltextzugriff (PDF)

Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status

Annals of hematology, 2020-12, Vol.99 (12), p.2911-2925

2020

Volltextzugriff (PDF)

Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study

Frontiers in immunology, 2023-01, Vol.13, p.1066748-1066748

2023

Volltextzugriff (PDF)

Haploidentical hematopoietic stem cell transplantation for a case with X‐linked chronic granulomatous disease

Pediatric transplantation, 2017-02, Vol.21 (1), p.np-n/a

2017

Volltextzugriff (PDF)

Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report

Blood, 2002-05, Vol.99 (9), p.3136-3143

2002

Volltextzugriff (PDF)

Unmanipulated haploidentical donor and matched unrelated donor hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria: a single-center study

Leukemia & lymphoma, 2022-05, Vol.63 (5), p.1211-1219

2022

Volltextzugriff (PDF)

Comparisons of unmanipulated haploidentical donor, unrelated cord blood donor and matched unrelated donor hematopoietic stem cell transplantation in pediatric acquired severe aplastic anemia: a single center study

Leukemia & lymphoma, 2022-12, Vol.63 (14), p.3307-3316

2022

Volltextzugriff (PDF)

Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation

Blood, 2006-04, Vol.107 (8), p.3065-3073

2006

Volltextzugriff (PDF)

Autologous peripheral blood stem cell transplantation for severe multiple sclerosis

International journal of hematology, 2006-10, Vol.84 (3), p.276-281

2006

Volltextzugriff (PDF)

HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: Improved outcomes in patients in accelerated phase and blast crisis phase

Annals of medicine (Helsinki), 2008, Vol.40 (6), p.444-455

2008

Volltextzugriff (PDF)

Hematopoietic stem cell transplantation for inherited bone marrow failure syndromes: alternative donor and disease-specific conditioning regimen with unmanipulated grafts

Hematology (Luxembourg), 2021-01, Vol.26 (1), p.134-143

2021

Volltextzugriff (PDF)

Sequential allogeneic and autologous CAR-T–cell therapy to treat an immune-compromised leukemic patient

Blood advances, 2018-07, Vol.2 (14), p.1691-1695

2018

Volltextzugriff (PDF)

Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease

Chinese medical journal, 2007-10, Vol.120 (19), p.1666-1671

2007

Volltextzugriff (PDF)

Surveillance of active human herpesvirus 6 infection in chinese patients after hematopoietic stem cell transplantation with 3 different methods

International journal of hematology, 2006-10, Vol.84 (3), p.262-267

2006

Volltextzugriff (PDF)

Attach more importance to recognize hemophagocytic lymphohistiocytosis

Chung-hua nei kʿo tsa chih, 2011-04, Vol.50 (4), p.273

Lu, Dao-Pei

2011

Volltextzugriff (PDF)

Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia

Biology of blood and marrow transplantation, 2018-09, Vol.24 (9), p.1881-1887

2018

Volltextzugriff (PDF)

Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma

Chinese medical journal, 2007-03, Vol.120 (6), p.463-468

2007

Volltextzugriff (PDF)

Mesenchymal stem cells in stem cell transplant recipients are damaged and remain of host origin

International journal of hematology, 2005-08, Vol.82 (2), p.152-158

2005

Volltextzugriff (PDF)

Purification of placenta-eluted gamma globulins and their strong effect against graft-versus-host reactions in vitro and in vivo

International journal of hematology, 2005-08, Vol.82 (2), p.162-168

2005

Volltextzugriff (PDF)

Two Kinds of HLA-mismatched Allogeneic Hematopoictic Stem Cell Transplantation for Treatment of Hematologic Malignancies

Zhongguo shi yan xue ye xue za zhi, 2016-04, Vol.24 (2), p.562

2016

Volltextzugriff (PDF)

1 – 25 von 227

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(152)

Publikationsform

Artikel
(226)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(163)
Male
(123)
Adult
(118)
Female
(118)
Middle Aged
(104)
Adolescent
(99)
Child
(62)
Life Sciences & Biomedicine
(43)
Science & Technology
(43)
Hematopoietic Stem Cell Transplantation
(42)
Transplantation, Homologous
(39)
Aged
(36)
Young Adult
(35)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(34)
Retrospective Studies
(34)
Child, Preschool
(31)
Hematology
(27)
Treatment Outcome
(23)
Follow-Up Studies
(22)
Hematopoietic Stem Cell Transplantation - Methods
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical hematopoietic stem cell transplantation: a single-center experience

Incidence, risk factors, and clinical outcomes associated with Epstein‐Barr virus‐DNAemia and Epstein‐Barr virus‐associated disease in patients after haploidentical allogeneic stem cell transplantation: A single‐center study

Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia

Immune reconstitution of HLA-A0201/BMLF1- and HLA-A1101/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell transplantation

Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo

Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study

Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status

Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study

Haploidentical hematopoietic stem cell transplantation for a case with X‐linked chronic granulomatous disease

Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report

Unmanipulated haploidentical donor and matched unrelated donor hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria: a single-center study

Comparisons of unmanipulated haploidentical donor, unrelated cord blood donor and matched unrelated donor hematopoietic stem cell transplantation in pediatric acquired severe aplastic anemia: a single center study

Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation

Autologous peripheral blood stem cell transplantation for severe multiple sclerosis

HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: Improved outcomes in patients in accelerated phase and blast crisis phase

Hematopoietic stem cell transplantation for inherited bone marrow failure syndromes: alternative donor and disease-specific conditioning regimen with unmanipulated grafts

Sequential allogeneic and autologous CAR-T–cell therapy to treat an immune-compromised leukemic patient

Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease

Surveillance of active human herpesvirus 6 infection in chinese patients after hematopoietic stem cell transplantation with 3 different methods

Attach more importance to recognize hemophagocytic lymphohistiocytosis

Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia

Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma

Mesenchymal stem cells in stem cell transplant recipients are damaged and remain of host origin

Purification of placenta-eluted gamma globulins and their strong effect against graft-versus-host reactions in vitro and in vivo

Two Kinds of HLA-mismatched Allogeneic Hematopoictic Stem Cell Transplantation for Treatment of Hematologic Malignancies

Suchergebnisse filtern